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Objective: To explore potential associations between proinﬂammatory cytokines in synovial ﬂuid and
progression of osteoarthritis (OA) in meniscectomized subjects.
Design: We studied 132 subjects on average 18 years after meniscectomy, with a second examination 4
e10 years later. We measured concentrations of interleukin (IL)-6, -8 and tumor necrosis factor (TNF)-a
by multiplex immunoassay, graded radiographic features of tibiofemoral and patellofemoral OA ac-
cording to the Osteoarthritis Research Society International (OARSI) atlas, scored patient-reported out-
comes using the Knee Injury and Osteoarthritis Outcome Score (KOOS), and used logistic regression
(adjusted for age, gender, body mass index, and time between examinations) for assessment of
associations.
Results: Higher ﬁrst examination concentrations of IL-6 and TNF-a were associated with increased risk
for subsequent osteophyte progression (odds ratios (OR); 95% conﬁdence intervals 1.05; 1.00e1.09 and
1.35; 1.03e1.75). Higher second examination concentrations of TNF-a were associated with having
progressed in loss of joint space (OR 1.70; 1.15e2.52) or having worsened in the activity of daily living
subscale of KOOS (OR 1.50; 1.07e2.09) in the preceding years. Subjects with increasing concentrations of
IL-6 or TNF-a between examinations were ﬁve times more likely to have progressed in joint space
narrowing between the same examinations, as compared to those with stable or decreasing concen-
trations (OR 5.17; 1.54e17.32 and 5.01; 1.32e18.92).
Conclusions: In subjects with previous meniscectomy, higher or over time increasing synovial ﬂuid levels
of IL-6 and TNF-a seems to be associated with increased risk for progression of radiographic OA.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Joint injury predisposes individuals to develop osteoarthritis
(OA)1. Injury to the meniscus and resection of the meniscus in-
crease the risk of knee OA by 2e7-fold2,3. The whole joint e artic-
ular cartilage, meniscus, ligaments, subchondral bone and: S. Larsson, Lund University,
nd, Sweden. Tel: 46-46-222-
rsson), martin.englund@med.
truglics), stefan.lohmander@
ternational. Published by Elsevier Lsynovium e is involved in the development of OA. Structural
changes in cartilage and bone can be monitored by serial radio-
graphic images where cartilage changes are measured as loss of
joint space width and bone changes are followed as formation of
osteophytes. Clinical outcome measures can be followed by self-
administered questionnaires, which measure patient-relevant
outcomes such as pain and function. Other ways to diagnose and
predict long-term OA outcome have been sought and may involve
soluble biomarkers.
OA used to be thought of as a disease due to wear and tear
without inﬂammatory processes, and is still classiﬁed as a non-
inﬂammatory disease based on the low leukocyte count found
in synovial ﬂuid4. However, in the last two decades, increasingtd. All rights reserved.
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emerged. Examples of inﬂammatory molecules implicated in
disease progression include interleukin (IL)-6 and tumor necrosis
factor (TNF)-a. IL-6 was reported to be elevated in synovial ﬂuid in
patients with focal cartilage defects5, and individuals with higher
circulating levels of IL-6 were reported to be more likely to have
radiographic knee OA6. Further, in an experimental canine model of
OA, high concentrations of IL-6 and TNF-a in synovial ﬂuid were
associated with early OA7. In the present exploratory study we
measured synovial ﬂuid concentrations of seven pro-inﬂammatory
cytokines (IL-1b, IL-6, IL-8, IL-10, IL-12p70, interferon [IFN]-g and
TNF-a) in a cohort of subjects with previous meniscectomy, to
explore how these cytokines associate with radiographic progres-
sion of OA and patient-relevant outcome measures.
Methods
Subjects
With informed consent from all subjects and approval by the
ethical review board at Lund University, we studied 132 subjects
from a cohort of 317 patients that were identiﬁed retrospectively to
have undergone isolated meniscectomy at Lund University hospital
in 1973, 1978 or between 1983 and 19858. The ﬁrst examinations
were performed 1994, 1995 or 2000, with a second examination of
all in 2004. The mean (range) time from meniscectomy to ﬁrst
examination was 18 (15e22) years and the time between ﬁrst and
second examinations was 7.5 (4e10) years [Fig. 2(A)]. ExclusionFig. 1. A ﬂowchart of inclusion and exclusion of sucriteria for the original cohort of 317 subjects were previous knee
surgery, meniscectomy in both knee compartments, osteochon-
dritis dissecans, fracture in or adjacent to the knee, septic arthritis,
osteonecrosis, any ligament injury, or radiographic signs of knee OA
at time of surgery8. Here we have further excluded subjects with
end-stage OA (described below) of the index knee at the ﬁrst ex-
amination, and one subject with extreme cytokine concentrations.
Of the 317 available subjects in the cohort, 132 were found eligible
for inclusion in the present study cohort (Fig. 1). A subset of 71
subjects had synovial ﬂuid available also from the second exami-
nation and was studied for investigation of longitudinal change in
synovial ﬂuid cytokine levels. With the exception of nine subjects
(which here lacked available synovial ﬂuid at the ﬁrst examination),
this study cohort of 132 subjects is the same as the cohort of 141
subjects studied in two previous publications on association be-
tween synovial ﬂuid concentrations of ARGS-aggrecan and pro-
gression of OA outcomes9,10.
Reference group
Sixteen individuals from the previously described reference
groupwithoutmeniscectomy or knee injury had synovial ﬂuids and
complete radiographic data available from the second examination
(Table I)8. This reference group was included to enable comparison
of cytokine levels between operated and non-operated persons of
similar age and gender distribution, and to verify that the subjects
of the study have increased risk of progressive radiographic
knee OA.bjects in the Study cohort and in the Subset.
Fig. 2. (A) A timeline of the study with mean (bold) and range years. Years in red,
mean time after ﬁrst examination for the reference group. (B) Scatter plots of indi-
vidual cytokine concentrations at ﬁrst (þ) and second () examinations with black box
plots summarizing the examinations using the timeline as x-axis. Boxes represent the
median and quartiles, whiskers the tenth and ninetieth percentiles, and the box widths
the relative sample sizes at the two examinations. Tables show median (twenty ﬁfth
and seventy ﬁfth percentiles) concentrations with P-values of related-samples Wil-
coxon signed-rank test from comparisons between cytokine levels at ﬁrst and second
examinations, and ManneWhitney U tests for comparisons between meniscal surgery
and reference group (REF, red text and boxes) at second examination.
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Semi-ﬂexed weight-bearing tibiofemoral (TF) and skyline
patellofemoral (PF) radiographs were obtained from both exami-
nations9. Using the 1995 atlas of Osteoarthritis Research Society
International (OARSI)11, we graded joint space narrowing (JSN) and
osteophytes in the TF and PF joints on a four point scale (0e3,
where 0 ¼ no evidence of JSN or osteophytes)9. Progression
from ﬁrst to second examination in the radiographic features
was evaluated separately as loss of joint space and osteophyte
progression, as well as combined to a radiographic OA (ROA)
score, with progression deﬁned as increase of one or more ingrade or score. This includes both incident JSN and osteophytes at
the second examination and worsening of already existing
changes.
ROA
We considered a knee to have ROA with any of the following:
1. JSN in any TF compartment or the PF compartment grade 2.
2. Sum of marginal osteophyte grades in the medial or lateral TF
compartment or the PF compartment 2.
3. JSN grade 1 and osteophyte grade 1 in the same TF compartment
or JSN grade 1 and osteophyte grade 1 in the PF compartment.
This cut-off approximates grade 2 TF OA on the Kellgren and
Lawrence (K/L) scale12.
End-stage OA
We considered a knee to have end-stage ROA either with JSN
grade 3 in any of the TF compartments or in the PF compartment, or
when a subject had undergone subsequent tibial osteotomy or
arthroplasty for OA.
Self-reported patient-relevant outcomes by KOOS
For assessment of patient-relevant outcomes we used the self-
administered questionnaire Knee injury and Osteoarthritis
Outcome Score (KOOS)13,14. The KOOS questionnaire covers ﬁve
patient-relevant subscales: pain, other symptoms, activity of daily
living, function in sports and recreation, and knee-related quality of
life, with scores ranging from 0 (worst) to 100 (best)13,14. We
evaluated the KOOS subscales separately and a decline between
examinations by 10 units or more was used as cut-off for a clinically
relevant worsening in all subscales15.
Measurement of cytokines in synovial ﬂuid
Synovial ﬂuid samples were aspirated without lavage from the
index knee joint of meniscectomized subjects and from reference
subjects, and were at the time of aspiration centrifuged at 3000 g
with the supernatant stored at 80C. To quantify synovial ﬂuid
concentrations of IL-1b, IL-6, IL-8, IL-10, IL-12p70, IFN-g and TNF-a,
we used a multiplex human pro-inﬂammatory 7-plex immuno-
assay from Meso Scale Discovery (MSD no. K15008C) with plates
analyzed in a MSD Sector Imager 6000. This assay is intended for
analysis in serum and plasma. Based on a previous investigation on
assay performance in synovial ﬂuid that tested recoveries to dilu-
tion, spiking and freeze thaw cycles16, synovial ﬂuids were diluted
1:4, which gave the following lower limits of quantiﬁcation (LLOQ):
IL-1b, 1.822 pg/ml; IL-6, 0.593 pg/ml; IL-8, 0.227 pg/ml; IL-10,
1.927 pg/ml; IL-12p70, 2.162 pg/ml; IFN-g, 1.299 pg/ml; TNF-a,
2.058 pg/ml. As reported, analyte stability appeared to be high for
all seven cytokines based on recovery to repeated freezeethaw
cycles16.
Statistical analysis
To assess normal distribution, we used the ShapiroeWilk test
with W  0.9 as a cut-off. Due to skewed distributions of cytokine
concentrations (also after log transformation), we used non-
parametric statistics when making comparisons between groups or
cytokines: the related-samples Wilcoxon signed-rank test for com-
parison of cytokine levels at ﬁrst and second examinations, the
ManneWhitney U test for comparison between the reference and
Table I
Characteristics and outcomes in the study cohort, the subset and the reference group
Study cohort n ¼ 132
(meniscectomized, all)
Subset n ¼ 71
(meniscectomized,
with synovial ﬂuid at both exams)
Reference group n ¼ 16
(without injury or operation)
Characteristics
Women 23 (17%) 12 (17%) 2 (12%)
Age at examination 1, years 52 (31e73) 51 (32e73) 53 (37e70)
Age at examination 2, years 59 (35e82) 58 (39e78) 62 (45e79)
Body mass index at examination 1, kg/m2 26 (18e41) 26 (18e41) 25 (20e31)
Years between index surgery and examination 1 18 (15e22) 18 (15e22) e
Years between examinations 1 and 2 7.6 (4.0e10.4) 7.5 (4.0e10.3) 8.6 (8.6e8.9)
Synovial ﬂuids available from examination 1 132 (100%) 71 (100%) 0 (0%)
Synovial ﬂuids available from examination 2 71 (54%) 71 (100%) 16 (100%)
Radiographic status at examinations
ROA at examination 1 75 (57%) 41 (58%) 1 (6%)
ROA at examination 2 101 (76%) 56 (79%) 1 (6%)
End-stage OA at examination 2 29 (22%) 17 (24%) 0 (0%)
Radiographic progression between exam 1 and 2
Loss of joint space/Progression of the JSN score 73 (55%) 39 (55%) Right 5 (31%), Left 1 (6%)
Osteophyte progression 62 (47%) 33 (46%) Right 2 (12%), Left 2 (12%)
ROA progression 93 (70%) 50 (70%) Right 7 (44%), Left 2 (12%)
KOOS score progression (worsening by 10 units) between exam 1 and 2
Pain 39 of 125 (31%) 22 of 66 (33%) 2 (12%)
Other symptoms 37 of 127 (29%) 23 of 68 (34%) 4 (25%)
Activity of daily living 27 of 125 (22%) 18 of 66 (27%) 1 (6%)
Function in sports and recreation 55 of 124 (44%) 31 of 67 (46%) 2 (12%)
Knee-related quality of life 46 of 127 (36%) 24 of 68 (35%) 1 (6%)
Values are numbers (%), or mean (range). There were no statistically signiﬁcant differences in characteristics or outcomes between the Study cohort and the Subset, except for
the availability in synovial ﬂuid samples at examination 2.
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of relationships between variables. Evaluations of differences in de-
mographics or outcomes between the study groups were done using
the Pearson's chi-square test for categorical variables and the Stu-
dent's t-test for normally distributed continuousdata. Although a risk
for type I errors exist due tomultiple testing, we did not usemultiple
test adjustments due to the exploratory character of the study.
We used multivariate binary logistic regression to assess asso-
ciations between cytokines and progression of OA outcomes. With
progression of outcomes from ﬁrst to second examination as
dependent variables, four variables were examined for each cyto-
kine: concentration at ﬁrst examination, concentration at second
examination, the degree of change in concentration between ex-
aminations (termed ‘delta concentration’), and the dichotomous
variable ‘increase vs no increase’ (where ‘no increase’ represents
both decreasing concentrations and over time stable concentra-
tions). The reported odds ratios (OR) reﬂect a one pg/ml higher
concentration, or having increased in concentration between ex-
aminations compared to not having increased, and were adjusted
for gender, age and body mass index at the ﬁrst examination, and
time between examinations.
To assess the discriminatory power of the biomarkers that were
statistically signiﬁcant in the adjusted logistic regression analyses,
we performed a receiver operator characteristics (ROC) curveTable II
Self-reported KOOS status at ﬁrst and second examinations in the study cohort, the subs
Study cohort n ¼ 132
(meniscectomized, all)
Examination 1 Examination 2
Pain 88 (18) 81 (20)
Other symptoms 86 (15) 80 (20)
Activity of daily living 89 (16) 86 (18)
Function in sports and recreation 67 (30) 62 (32)
Knee-related quality of life 75 (24) 69 (26)
Values of KOOS scores are mean (SD) with scores ranging from 0 (worst) to 100 (best). Th
cohort and the Subset.analysis17. The area under the ROC curve (AUC) and the optimal
discriminative cut-off concentration for each dependent outcome
was determined. Using these cut-offs, (or the dichotomous increase
vs no increase as cut-off) we calculated the sensitivity, speciﬁcity,
and the positive and negative predictive values (PPV and NPV) for
the biomarkers. All tests were two-sided with P-values below 0.05
considered to be statistically signiﬁcant and were performed using
IBM SPSS Statistics version 21 for Mac OS.
Results
Subject characteristics
We noted no statistically signiﬁcant differences between the
study cohort (all meniscectomized, n ¼ 132) and the subset
(meniscectomized with synovial ﬂuid available from both exami-
nations, n ¼ 71) regarding patient characteristics, radiographic
status or KOOS scores at either examination, or change in radio-
graphic status or KOOS scores from ﬁrst to second examination
(Tables I and II). Regarding status and progression of radiographic
features and KOOS scores, the study cohort and the subset were
substantially different from the un-operated reference group, with
higher prevalence of radiographic and end-stage OA, higher pro-
portion of radiographic progression and KOOS score worsening,et and the reference group
Subset n ¼ 71 (meniscectomized,
with synovial ﬂuid at both exams)
Reference group n ¼ 16 (without
injury or operation)
Examination 1 Examination 2 Examination 1 Examination 2
89 (15) 83 (17) 95 (12) 96 (6)
87 (13) 81 (18) 93 (12) 91 (10)
90 (14) 86 (16) 96 (9) 98 (4)
68 (28) 62 (33) 90 (23) 88 (20)
77 (21) 70 (26) 92 (15) 95 (11)
ere were no statistically signiﬁcant differences in KOOS subscales between the Study
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tions (Tables I and II)8,18.
Cytokine measurements
Proportion of detectable samples
With samples diluted to capture a majority of the cytokines in
the optimal reading range, four of the analyzed cytokines (IL-1b, IL-
10, IL-12p70, and IFN-g) had a large proportion (between 68% and
97%) of the samples with concentrations below their respective
LLOQ; therefore, these cytokines were excluded from further study.
For the remaining cytokines the proportion of samples having
concentrations below LLOQ were 19, 0, and 14% for IL-6, IL-8 and
TNF-a, respectively; these cytokines were used for further analysis
with imputed values (half the LLOQ) used for samples having
concentrations below LLOQ.
Synovial ﬂuid concentrations of IL-6, IL-8 and TNF-a at ﬁrst and
second examinations
At group level, synovial ﬂuid concentrations of IL-6, IL-8 and
TNF-a at the ﬁrst examination (15e22 years after meniscectomy)Table III
Correlation matrix of synovial ﬂuid cytokine concentrations and outcomes at ﬁrs
parenthesis, with statistically signiﬁcant correlations in bold. Correlation strength is in
(deepening shades of orange)all increased to the second examination 4e10 years later [Fig. 2(A)
and (B)]. The increases in median concentrations were 2.7-, 1.7-,
and 1.6-fold for IL-6, IL-8 and TNF-a, respectively. Compared to the
similarly aged reference group, the median concentrations at sec-
ond examination of IL-6 and IL-8 were 3.1 and 1.5 times higher,
whereas the TNF-a concentration was no different from that of the
reference group [Fig. 2(B)].
Correlations between cytokines within and between examinations
Concentrations of IL-6 and IL-8 correlated between the ﬁrst and
second examinations (rS¼ 0.418 and 0.480, respectively; P < 0.001),
whereas TNF-a did not showany correlation between examinations
(rS ¼ 0.232, P ¼ 0.052). All three cytokines correlated with each
other, both at the ﬁrst and the second examination (Table III).
Correlations between cytokines and outcome measures within
examinations
Overall, cytokine concentrations correlated positively with
radiographic scores and negatively with self-reported scores of the
KOOS subscales (Table III). The only exceptionwas TNF-a, for which
there was no statistically signiﬁcant correlation with thet and second examinations. Spearman's correlation coefﬁcients with p-values in
dicated by a heat map ranging from no correlation (white) to stronger correlation
S. Larsson et al. / Osteoarthritis and Cartilage 23 (2015) 1906e1914 1911osteophyte sum score at any of the visits (Table III). There was
further an overall high similarity in correlations between cytokine
concentrations and outcome scores at the ﬁrst and second exami-
nations, albeit with a general increase in the strength of the cor-
relations from ﬁrst to second examination (Table III).
Association between synovial ﬂuid cytokines and subsequent
progression of OA
At the ﬁrst examination, 15e22 years after meniscectomy, there
was an overall trend for increased likelihood of progression of
radiographic features of OA over the next 4e10 years with higherTable IV
Cytokines as biomarkers of progression of OA outcomes. OR with 95% CI from logistic
cytokine concentrations over time (Delta conc.), or dichotomized as decreasing over ti
increased in concentration between examinations compared to not having increased, w
between ﬁrst and second examinations. Statistically signiﬁcant associations are indicate
Synovial fluid conc. at 
exam 1
Synovia
OR (95% CI) p-value OR (95
Radiographic progression
Loss of joint space IL-6 1.02  (0.99, 1.06) 0.157 1.00 (1.0
IL-8 1.04  (0.99, 1.09) 0.158 1.00 (1.0
TNF-α 1.01  (0.80, 1.28) 0.923 1.70 (1.1
Osteophyte progression IL-6 1.05  (1.00, 1.09) 0.049 1.00 (1.0
IL-8 1.05  (0.99, 1.10) 0.092 1.00 (0.9
TNF-α 1.35  (1.03, 1.75) 0.027 1.05 (0.8
ROA progression IL-6 1.05  (0.98, 1.13) 0.154 1.00 (0.9
IL-8 1.03  (0.97, 1.10) 0.346 1.00 (0.9
TNF-α 1.24  (0.90, 1.70) 0.182 1.27 (0.9
KOOS progression
Pain IL-6 1.01  (0.99, 1.03) 0.169 1.00 (0.9
IL-8 1.02  (0.97, 1.08) 0.388 1.00 (0.9
TNF-α 1.12 (0.87, 1.44) 0.374 1.16 (0.8
Other symptoms IL-6 1.00  (0.98, 1.02) 0.950 1.00 (0.9
IL-8 1.00  (0.95, 1.06) 0.885 1.00 (0.9
TNF-α 1.08  (0.84, 1.40) 0.535 0.97 (0.7
Activity of daily living IL-6 1.01  (1.00, 1.03) 0.158 1.01 (1.0
IL-8 1.04  (0.99, 1.10) 0.161 1.00 (0.9
TNF-α 1.18  (0.90, 1,55) 0.226 1.50 (1.0
Function in sports and recreation IL-6 1.08  (1.01, 1.14) 0.017 1.00 (0.9
IL-8 1.04  (0.98, 1.09) 0.184 1.00 (0.9
TNF-α 1.06  (0.83, 1.36) 0.641 1.17 (0.8
Knee-related quality of life IL-6 1.02  (0.99, 1.04) 0.153 1.00 (1.0
IL-8 1.03  (0.98, 1.08) 0.221 1.00 (0.9
TNF-α 1.16  (0.90, 1.48) 0.248 0.81 (0.5synovial ﬂuid cytokine levels (mean OR 1.1; Table IV). This wasmost
pronounced for progression of osteophytes, for which higher con-
centrations of both IL-6 and TNF-a were independently associated
with progression. The strongest association was seen for TNF-a,
where the likelihood of osteophyte progression increased by 1.4-
fold for every pg/ml higher concentration of TNF-a (OR 1.35; 95%
conﬁdence intervals (CI) 1.03e1.75) at the ﬁrst examination; for IL-
6 the association was more modest with a 1.05-fold increased
likelihood of osteophyte progression per pg/ml higher concentra-
tion (OR 1.05; 1.00e1.09) (Table IV). Associations between cytokine
concentrations at ﬁrst examination and subsequent progression of
patient-relevant KOOS subscales were less pronounced; the onlyregression analysis based on synovial ﬂuid concentrations of cytokines, or change in
me or not. The reported OR's reﬂect a one pg/ml higher concentration, or having
ith adjustments for sex, age and body mass index at ﬁrst examination, and time
d in blue and bold
l fluid conc. at 
exam 2
Delta conc.
(exam 2 – exam 1)
Increased conc.
(exam 2 > exam 1)
% CI) p-value OR (95% CI) p-value OR (95% CI) p-value
0, 1.01) 0.251 1.00  (1.00, 1.01) 0.353 5.17 (1.54, 17.32) 0.008
0, 1.01) 0.817 1.00  (0.99, 1.01) 0.838 2.37 (0.65, 8.61) 0.192
5, 2.52) 0.008 1.34  (1.06, 1.71) 0.016 5.01 (1.32, 18.92) 0.018
0, 1.01) 0.871 1.00  (0.99, 1.01) 0.767 1.51 (0.49, 4.66) 0.472
9, 1.01) 0.748 1.00  (0.99, 1.01) 0.680 1.33 (0.37, 4.79) 0.659
2, 1.36) 0.698 0.90  (0.73, 1.11) 0.328 0.71 (0.22, 2.35) 0.576
9, 1.01) 0.649 1.00  (0.99, 1.01) 0.831 2.70 (0.80, 9.13) 0.111
9, 1.01) 0.634 1.00  (0.99, 1.01) 0.633 2.73 (0.67, 11.03) 0.159
1, 1.76) 0.157 1.07  (0.84, 1.37) 0.587 1.41 (0.36, 5.55) 0.628
9, 1.01) 0.911 1.00  (0.99, 1.01) 0.947 1.02 (0.29, 3.52) 0.981
9, 1.01) 0.990 1.00  (0.99, 1.01) 0.969 1.29 (0.30, 5.64) 0.732
8, 1.54) 0.292 1.11 (0.88, 1.38) 0.378 1.72 (0.40, 7.34) 0.463
9, 1.01) 0.483 1.00  (0.99, 1.01) 0.524 1.71 (0.46, 6.37) 0.424
9, 1.01) 0.852 1.00  (0.99, 1.01) 0.931 1.63 (0.37, 7.16) 0.521
2, 1.31) 0.850 0.99  (0.79, 1.24) 0.914 1.27 (0.32, 5.04) 0.738
0, 1.01) 0.160 1.01  (1.00, 1.01) 0.151 0.97 (0.24, 3.89) 0.960
9, 1.01) 0.744 1.00  (0.99, 1.01) 0.805 0.99 (0.21, 4.57) 0.985
7, 2.09) 0.018 1.25  (0.97, 1.62) 0.090 7.25 (0.81, 65.33) 0.077
9, 1.01) 0.919 1.00  (0.99, 1.01) 0.724 1.29 (0.38, 4.32) 0.685
9, 1.01) 0.768 1.00  (0.99, 1.01) 0.743 1.24 (0.33, 4.67) 0.746
9, 1.53) 0.269 1.09  (0.88, 1.34) 0.433 1.65 (0.45, 6.09) 0.451
0, 1.01) 0.834 1.00  (0.99, 1.01) 0.846 0.73 (0.21, 2.57) 0.628
9, 1.01) 0.763 1.00  (0.99, 1.01) 0.788 0.67 (0.18, 2.53) 0.551
8, 1.11) 0.187 0.83  (0.65, 1.06) 0.137 0.86 (0.23, 3.19) 0.827
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KOOS subscale function in sports and recreation, for which the
likelihood of worsening was 1.08 (1.01e1.14) per pg/ml higher
concentrations of IL-6 (Table IV).
Association between synovial ﬂuid cytokines and prior or
concomitant progression of OA
At the second examination, TNF-a was the only cytokine to
show any association with progression of outcomes in the pre-
ceding four to ten years; for every pg/ml higher concentration of
TNF-a, the likelihood for progression of loss of joint space and
worsening in activity of daily living increased 1.7- and 1.5-fold
respectively (OR 1.70; 1.15e2.52 and 1.50; 1.07e2.09) (Table IV).
Since we noted an increase in all three cytokines from ﬁrst to
second examination at a group level [Fig. 2(B)], we examined if the
degree of change between visits (‘delta concentration’) was asso-
ciated with concomitant progression of outcomes. We found that
only increase in TNF-a was associated with progression of out-
comes; an increase in TNF-a concentration from ﬁrst to second visit
by 1 pg/ml increased the likelihood of concomitant progression of
loss of joint space by 1.3-fold (OR 1.34; 1.06e1.71) (Table IV).
To explore the consequence of an increase in cytokine concen-
tration between visits compared to not having an increase, we
dichotomized change in cytokine concentration between visits as
‘increasing vs not increasing’. We found that those who had
increased in concentrations of IL-6 or TNF-a from ﬁrst to second
examinations had a 5-fold increased likelihood of having pro-
gressed in loss of joint space in the same time period (OR's 5.17;
1.54e17.32 and 5.01; 1.32e18.92, respectively) as compared to
those with stable or decreasing concentrations (Table IV).
The discriminatory power of the biomarkers associated with OA
Biomarkers predictive of subsequent progression
With similar AUC between 0.6 and 0.7, both IL-6 and TNF-a at
ﬁrst examination were predictive of osteophyte progression
(Table V). Of the two, IL-6 was more sensitive (68%) but less speciﬁc
(61%) for identiﬁcation of progressors than TNF-a (55% sensitivity
and 70% speciﬁcity), both with positive and negative predictive
values around 60% at cut-offs close to their respective median
concentrations (Table V).
For identiﬁcation of progressors in KOOS function in sports and
recreation, ﬁrst examination IL-6 concentrations had a similar AUC
as for identiﬁcation of osteophyte progressors, but the cut-off was
higher (4.41 pg/ml compared to 1.64 pg/ml) and the sensitivity of
51% was the lowest of all the tested biomarkers (Table V).
Biomarkers of prior and concomitant progression
At almost identical cut-offs of 5 pg/ml and with AUC above 0.7,
the sensitivity and speciﬁcity of second examination TNF-awas 74%Table V
Discriminative power of biomarkers associated with progression of OA.
Classiﬁcation Biomarker Diagnosis, worsening/progression of AU
Predictive IL-6, exam 1 Osteophyte score 0.6
IL-6, exam 1 KOOS function in sports and recreation 0.7
TNF-a, exam 1 Osteophyte score 0.6
Retrospective TNF-a, exam 2 JSN score 0.7
TNF-a, exam 2 KOOS activity of daily living 0.7
Concurrent Delta TNF-a (2e1) JSN score 0.7
Increasing IL-6 (2 >1) JSN score 0.7
Increasing TNF-a (2 >1) JSN score 0.7
* Using the AUC for Delta IL-6 respective Delta TNF-a at a different, suboptimal, cut-oand 75% for correctly diagnosing prior progression of JSN, and 89%
and 63% for capturing those who had worsened in KOOS activity of
daily living (Table V).
To identify concurrent progression in JSN, increasing TNF-a had
the highest sensitivity (90%) but also the lowest speciﬁcity (34%)
with a high negative predictive value of 73% (meaning that 73% of
those who had not increased in TNF-a, i.e., decreased or been stable
in TNF-a levels over time, had not worsened in the JSN score over
the same time) (Table V). The same high negative predictive value
was noted for increasing IL-6, although with a slightly lower
sensitivity (85%) but a better speciﬁcity (50%) for detection of
concomitant progression (Table V).
In comparison to having increased or not in TNF-a between the
two examinations, delta TNF-a (the change in TNF-a concentra-
tions) had a higher speciﬁcity (78%) for identiﬁcation of concurrent
progressors of JSN and a higher positive predictive value (78%), but
at a cost of lower sensitivity (64%) and a lower negative predictive
value (64%) (Table V).Discussion
In this exploratory study we found that 15e22 years after a
meniscal tear, higher or over time increasing levels of IL-6 and TNF-
a in the joint ﬂuid was associated with increased risk for progres-
sion of radiographic features of OA. We further found that of the
four conditions tested e concentrations at ﬁrst or second exami-
nations, change in concentration between examinations, or in-
crease vs not increase in concentration between examinations e
increase in IL-6 or TNF-a between examinations showed the
strongest association with worsening, with a ﬁve-fold increased
likelihood of having concurrently progressed in loss of joint space.
Increase in IL-6 and TNF-a further had the highest sensitivity for
correctly identifying concurrent progression in JSN (85% and 90%,
respectively), with the strongest negative predictive values (both
73%), meaning that 73% of those who were stable or without in-
crease in IL-6 or TNF-a concentration did not have concomitant
progressive JSN. This indicates that although the actual cytokine
concentration at one given examination is of some importance, the
change in levels over time appears to be more important for the
long-term outcome in these patients.
As biomarkers predictive of outcome, only ﬁrst examination
concentrations can, however, be described as predictive in this
study, since change of biomarker concentrations and progression
of OA outcomes were studied in the same time window. Both IL-
6 and TNF-a showed such predictive capacity, where subjects
with higher synovial ﬂuid concentrations of IL-6 or TNF-a at ﬁrst
examination were more likely to have progressed in the osteo-
phyte score four to ten years later. The risk associated with
higher synovial ﬂuid levels was highest for TNF-a, and TNF-a was
more speciﬁc but less sensitive in correctly identifying pro-
gressors than IL-6.C P-value Cut-off, pg/ml PPV, % NPV, % Sensitivity, % Speciﬁcity, %
83 <0.001 1.64 61 68 68 61
07 <0.001 4.41 80 70 51 90
33 0.009 3.44 62 64 55 70
49 <0.001 5.06 78 71 74 75
92 <0.001 5.00 47 94 89 63
12 0.002 1.86 78 64 64 78
38* 0.001 Delta IL-6 > 0 67 73 85 50
12* 0.002 Delta TNF-a > 0 63 73 90 34
ffs.
S. Larsson et al. / Osteoarthritis and Cartilage 23 (2015) 1906e1914 1913Although both IL-6 and TNF-a were predictive of subsequent
osteophyte progression, all of the retrospective or concurrent as-
sociations found involved progression of JSN and not progression
of osteophytes. This can be interpreted as a more inﬂuential role
for IL-6 and TNF-a on cartilage loss than on bone remodeling in
these subjects. Another possible interpretation is that cartilage
loss and the associated release of cartilage matrix constituents to
the synovial space cause increased local inﬂammation, here
measured as increase in the synovial ﬂuid levels of IL-6 and TNF-a.
In support, human knee joints after injury or with OA contain
highly elevated levels of tenascin-C fragments that correlate with
markers of cartilage degradation and inﬂammation19. Fragments
of tenascin-C stimulate the production of proinﬂammatory cyto-
kines in human macrophages and synovial ﬁbroblasts through
activation of toll-like receptor-4 (TLR4)20. We, and others, have
previously shown that both IL-6 and TNF-a are greatly increased in
synovial ﬂuid early after injury16,21e24, with a gradual decrease
with time after injury16,21. Others have shown that intra-articular
injection of TNF-a in the rat serve as an acute and reversible
in vivo model of cartilage proteoglycan degradation25, supporting
the associations here seen between retrospective and concurrent
JSN and TNF-a. Prospective studies will be needed to elucidate
whether higher local IL-6 and TNF-a joint concentrations in these
subjects many years after injury are a cause or a consequence
of JSN.
Patient-reported outcomes were to a lesser degree than radio-
graphic features associated with cytokine concentrations in the
knee joint. The strongest association was seen for the second ex-
amination TNF-a, where higher concentration was associated with
a 1.5-fold increased likelihood of having worsened in the KOOS
subscale activity of daily living up to that examination, compared to
a 1.7-fold increased risk of having progressed in JSN. Both associ-
ated risks had an optimal cut-off at the median TNF-a concentra-
tion of 5 pg/ml with similar AUC close to 0.8. However, only 47% of
the subjects that had TNF-a concentrations above the cut-off had
worsened in activity of daily living, whereas 78% had progressed in
loss of joint space in the same time, as shown by their respective
PPV's (Table V). Higher concentrations of IL-6 at ﬁrst examination
marginally increased the likelihood of worsening in the sports and
recreation subscale by 1.08-fold, similar in magnitude to the 1.05-
fold increased risk of progression in osteophytes in the coming
years.
Previous reports on the association of cytokine levels, and
changes in those levels over time, with OA are somewhat con-
ﬂicting. Serum levels of IL-6 and TNF-a were associated with knee
cartilage loss over 2.9 years in older people26, while women with
higher IL-6 levels in serum were more likely to be diagnosed as
having radiographic knee OA 5 years later6. IL-6 was also reported
to be elevated in synovial ﬂuid in patients with focal cartilage de-
fects5. In contrast, IL-6 concentrations in synovial ﬂuid were
inversely related with Kellgren and Lawrence radiographic grade in
subjects with knee OA27. These differences, together with OR and CI
close to one, and risks of confounding in observational studies,
suggests a cautious interpretation of the associations noted for
cytokines at ﬁrst examination.
Our study has several limitations. Only about half of the subjects
included in the study had synovial ﬂuid available from both
examinations. Variable clearance rates of cytokines from the joint
cavity might have inﬂuenced the concentrations measured,
emphasizing that the solute concentrations measured in the sy-
novial ﬂuid are a result of both inﬂow and outﬂow from the
compartment28. We investigated changes in cytokine concentra-
tions and progression in the same time window (to examine if
change in cytokine concentration is predictive of progression in this
study, an intermediary follow up would have been needed): thenoted association between change in cytokine concentrations and
concurrent progression of OA are however consistent with the
predictive role of IL-6 and TNF-a discussed above. The synovial
ﬂuids used herein have been thawed once or twice in the course of
previous investigations9,10, but although cytokine stability was not
studied here, we have previously noted a good stability to up to ten
freezeethaw cycles for all the analyzed cytokines using this assay16.
Due to the exploratory nature of the study, we chose not to adjust
for multiple testing, and results should therefore be interpreted
with caution. Nevertheless, in a clinical perspective, where blocking
agents have been proposed for potential use in the acute phase after
knee-injury to improve the long-term outcome for subjects with
knee injury29,30, and treatment speciﬁc targeting of patients based
on their immunological proﬁle has been suggested31, our results
merit further investigation.
In conclusion, we found that in subjects with previous menis-
cectomy, having high or over time increasing synovial ﬂuid levels of
IL-6 and TNF-awas associatedwith increased risk for subsequent or
concurrent progression of ROA, and that synovial ﬂuid concentra-
tions of IL-6 and TNF-a were predictive of osteophyte progression.
Thus, IL-6 and TNF-a in synovial ﬂuid may be useful as biomarkers
e alone or in combination with other biomarkers e to identify
subjects at risk for radiographic progression of OA, and may further
represent valid treatment targets in knee OA.
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